Improving postpartum care for new mothers
Comparing Standard of Care Versus a Technology-Based Approach To Reduce Postpartum Emergency Department Visits
NA · Medical University of South Carolina · NCT06273436
This study tests if a text message program can help new mothers in South Carolina get better postpartum care and catch health problems early compared to regular in-person visits.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 2894 (estimated) |
| Ages | 16 Years to 49 Years |
| Sex | Female |
| Sponsor | Medical University of South Carolina (other) |
| Locations | 1 site (Charleston, South Carolina) |
| Trial ID | NCT06273436 on ClinicalTrials.gov |
What this trial studies
This research aims to evaluate the effectiveness of AIM safety bundles for postpartum women by comparing traditional in-person care with a text message-based program designed to enhance early detection of complications. Participants will complete surveys at enrollment and three additional times over the year, with follow-up support from nurse advocates if complications are reported. The study focuses on women experiencing significant health disparities in South Carolina, ensuring they receive timely medical care during the critical first six weeks postpartum.
Who should consider this trial
Good fit: Ideal candidates are postpartum women aged 16-49, within two weeks of delivery, insured by Medicaid, and residing in South Carolina.
Not a fit: Patients who do not speak English or Spanish, plan to relocate or discontinue Medicaid, or are currently incarcerated may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the early detection and management of postpartum complications for new mothers.
How similar studies have performed: Other studies have shown promise in using text-based interventions for improving maternal health outcomes, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria for Postpartum Women * Postpartum woman within approximately 2 weeks of delivering a baby of gestational age ≥ 26 weeks in South Carolina. * Aged 16-49 years old. * Insured by Medicaid. Exclusion Criteria for Postpartum Women * Plans to relocate outside of SC anytime during the postpartum year. * Plans to discontinue Medicaid health insurance during the postpartum year. * Speaks a language other than English or Spanish. * Incarcerated/pending incarceration during peripartum period. * Currently institutionalized. * Enrolled in current MUSC study funded by PCORI (#Pro00123833) * Does not have and/or does not wish to use their personal cell phone for the study. Inclusion Criteria for Obstetric Providers and Hospital Administrators \- OB provider working at a delivery hospital in SC and directly involved in the care of postpartum women; or hospital administrator working in a delivery hospital in SC and job responsibilities relate to the postpartum unit. Exclusion Criteria for Obstetric Providers and Hospital Administrators * Less than 1 month of HEAR 4 Mamas experience if involved in the hospital where participants are recruited from. * Unable or unwilling to commit to completing surveys or an interview. * Speaking a language other than English.
Where this trial is running
Charleston, South Carolina
- Medical University of South Carolina — Charleston, South Carolina, United States (RECRUITING)
Study contacts
- Study coordinator: Constance Guille, MD
- Email: guille@musc.edu
- Phone: 843-792-6489
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Postpartum Complication, AIM safety bundles, Randomized Controlled Trial, Emergency Department visits, Shared Decision Making, Patient-Reported Outcomes, Patient Stakeholder Group, Study Advisory Committee